Te­va tem­porar­i­ly pad­locks a plant af­ter FDA cites it for con­t­a­m­i­na­tion

Af­ter FDA in­ves­ti­ga­tors un­veiled a list of prob­lems that were found at a Te­va Phar­ma­ceu­ti­cals plant in Irvine, CA, in­clud­ing mold stem­ming from wa­ter leaks, the com­pa­ny said it will halt pro­duc­tion at that site un­til it is able to meet qual­i­ty ex­pec­ta­tions.

A Te­va spokesper­son con­firmed the tem­po­rary man­u­fac­tur­ing stop­page Mon­day morn­ing in an email to End­points News, say­ing that that pro­duc­tion will re­sume af­ter a re­view is con­duct­ed.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.